Matthews Elizabeth A, Dickenson Anthony H
Department of Pharmacology, University College London, London, United Kingdom. e,
Anesthesiology. 2002 Mar;96(3):633-40. doi: 10.1097/00000542-200203000-00020.
Peripheral nerve damage can result in severe, long-lasting pain accompanied by sensory deficits. This neuropathic pain remains a clinical problem, and effective morphine analgesia is often limited by intolerable side effects. The antiepileptic gabapentin has recently emerged as an alternative chronic pain treatment. Improved management of the diverse symptoms and mechanisms of neuropathic pain may arise from combination therapy, based on multiple pharmacologic targets and low drug doses.
The authors used the Kim and Chung rodent model of neuropathy to induce mechanical and cold allodynia in the ipsilateral hind paw. In vivo electrophysiologic techniques were subsequently used to record evoked dorsal horn neuronal responses in which the effects of systemic morphine and gabapentin were investigated, both individually and in combination.
Morphine (1 and 4 mg/kg) inhibited neuronal responses of control rats but not after neuropathy. Gabapentin (10 and 20 mg/kg) inhibited neuronal responses in nerve injured rats and to a lesser extent in sham rats but not in naive rats. In the presence of gabapentin (ineffective low dose of 10 mg/kg), morphine (1 and 3 mg/kg) mediated significant inhibitory effects in all experimental groups, with the greatest inhibitions observed in spinal nerve-ligated and sham-operated rats. After neuropathy, inhibitions mediated by morphine were significantly increased in the presence of gabapentin compared with morphine alone.
After spinal nerve ligation, the inhibitory effects of systemic morphine on evoked dorsal horn neuronal responses are reduced compared with control, whereas the effectiveness of systemic gabapentin is enhanced. In combination with low-dose gabapentin, significant improvement in the effectiveness of morphine is observed, which demonstrates a clinical potential for the use of morphine and gabapentin combinational treatment for neuropathic pain.
周围神经损伤可导致严重的、长期的疼痛并伴有感觉缺陷。这种神经性疼痛仍然是一个临床问题,有效的吗啡镇痛常常受到难以耐受的副作用的限制。抗癫痫药物加巴喷丁最近已成为一种治疗慢性疼痛的替代药物。基于多种药理靶点和低药物剂量的联合治疗可能会改善对神经性疼痛的多种症状和机制的管理。
作者使用金氏和钟氏啮齿动物神经病变模型在同侧后爪诱导机械性和冷觉异常性疼痛。随后使用体内电生理技术记录诱发的背角神经元反应,研究全身应用吗啡和加巴喷丁单独及联合应用的效果。
吗啡(1和4毫克/千克)抑制对照大鼠的神经元反应,但在神经病变后则无此作用。加巴喷丁(10和20毫克/千克)抑制神经损伤大鼠的神经元反应,对假手术大鼠的抑制作用较小,对未处理大鼠则无抑制作用。在加巴喷丁(无效低剂量10毫克/千克)存在的情况下,吗啡(1和3毫克/千克)在所有实验组中均介导显著的抑制作用,在脊神经结扎和假手术大鼠中观察到的抑制作用最大。神经病变后,与单独使用吗啡相比,加巴喷丁存在时吗啡介导的抑制作用显著增强。
与对照相比,脊神经结扎后全身应用吗啡对诱发的背角神经元反应的抑制作用减弱,而全身应用加巴喷丁的有效性增强。与低剂量加巴喷丁联合使用时,观察到吗啡有效性有显著改善,这表明吗啡和加巴喷丁联合治疗神经性疼痛具有临床应用潜力。